1. Home
  2. SEI vs PCRX Comparison

SEI vs PCRX Comparison

Compare SEI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEI
  • PCRX
  • Stock Information
  • Founded
  • SEI 2014
  • PCRX 2006
  • Country
  • SEI United States
  • PCRX United States
  • Employees
  • SEI N/A
  • PCRX N/A
  • Industry
  • SEI
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SEI
  • PCRX Health Care
  • Exchange
  • SEI NYSE
  • PCRX Nasdaq
  • Market Cap
  • SEI 1.2B
  • PCRX 1.2B
  • IPO Year
  • SEI 2017
  • PCRX 2011
  • Fundamental
  • Price
  • SEI $31.40
  • PCRX $22.90
  • Analyst Decision
  • SEI Strong Buy
  • PCRX Buy
  • Analyst Count
  • SEI 8
  • PCRX 8
  • Target Price
  • SEI $43.71
  • PCRX $28.38
  • AVG Volume (30 Days)
  • SEI 1.3M
  • PCRX 545.0K
  • Earning Date
  • SEI 07-23-2025
  • PCRX 07-29-2025
  • Dividend Yield
  • SEI 1.54%
  • PCRX N/A
  • EPS Growth
  • SEI N/A
  • PCRX N/A
  • EPS
  • SEI 0.50
  • PCRX N/A
  • Revenue
  • SEI $371,533,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • SEI $65.83
  • PCRX $7.54
  • Revenue Next Year
  • SEI $35.50
  • PCRX $10.78
  • P/E Ratio
  • SEI $61.95
  • PCRX N/A
  • Revenue Growth
  • SEI 33.59
  • PCRX 3.08
  • 52 Week Low
  • SEI $10.96
  • PCRX $11.16
  • 52 Week High
  • SEI $39.03
  • PCRX $27.64
  • Technical
  • Relative Strength Index (RSI)
  • SEI N/A
  • PCRX 35.82
  • Support Level
  • SEI N/A
  • PCRX $22.82
  • Resistance Level
  • SEI N/A
  • PCRX $23.83
  • Average True Range (ATR)
  • SEI 0.00
  • PCRX 0.74
  • MACD
  • SEI 0.00
  • PCRX -0.02
  • Stochastic Oscillator
  • SEI 0.00
  • PCRX 6.22

About SEI SOLARIS ENERGY INFRASTRUCTURE INC

Solaris Energy Infrastructure Inc provides services in the oil and gas industry. Its solutions are Solaris software suite, Fluid management system, Automated control systems, Field services, Last mile management, Wet sand solutions, Power Solutions, and Integrated wellsite solution. Its segment include Solaris Power Solutions and Solaris Logistics Solutions. It derives maximum revenue from Solaris Logistics Solutions segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: